Pathway

Pathway is now a part of @doximity!

[Jon Hershon @jonathanhershon]

Prescribing is something physicians do dozens of times a day. The act itself is simple. What happens after often isn’t.

Coverage questions, pharmacy callbacks, transfer requests. Time that should go to patients gets pulled elsewhere.

Today, @doximity is launching Prescribe in partnership with @photonhealth to make prescribing easier for physicians and patients.

Physicians can write a prescription directly inside Doximity.

Patients then get a text to choose their preferred pharmacy and see estimated pricing before pickup.

That’s it.

No new portals. No separate logins.

It starts inside Dialer, works on any device, and is completely free for verified physicians, NPs, and PAs.

It’s also the next piece of the workflow we’ve been building toward -- the visit, the note, the clinical question, and now the prescription, all in one place, built for the people delivering care.

Link to learn more in comments.

[Pathway @PathwayMedical]

Hey Nishant, sorry to hear that’s been your experience. The response in your screenshot doesn’t look fully loaded - did it stop there? Please reach out to us at [email protected] and we’ll help sort it out. We really appreciate the feedback and want to make sure you’re getting the best experience with Pathway.

[Jon Hershon @jonathanhershon]

Having the chance to work alongside Jeff, who has shaped how clinicians connect, learn, and deliver care for decades, has been a privilege. Proud that Pathway is now part of this story.

[Jon Hershon @jonathanhershon]

Thrilled to share that @PathwayMedical has been acquired by @doximity.

Seven years ago, @LouisMullie, Chris, and I set out with a simple vision: use technology to make it easier for clinicians to care for patients.

Today, Pathway is in the hands of hundreds of thousands of healthcare professionals, helping them answer millions of clinical questions.

That mission is what first connected me with Jeff Tangney, Doximity’s co-founder and CEO. Jeff previously co-founded Epocrates, the first medical app for the iPhone, and helped define mobile clinical reference for a generation of providers.

That same spirit drives Doximity today, now home to over 80% of U.S. physicians and deeply embedded in how healthcare professionals connect, stay informed, and deliver care.

Bringing Pathway and Doximity together means accelerating our roadmap and putting the next generation of evidence-based clinical reference in the hands of millions, for free.

I'm incredibly excited to build alongside the talented Doximity team to make that vision real.

None of this would have been possible without a brilliant team who made the mission their own, and the mentors, friends, investors, and partners who believed in us.

Grateful for the last chapter, and energized for what's ahead.

We're just getting started.

[Louis Mullie, MD @LouisMullie]

Very excited to be part of this journey! We’re moving forward with our eyes set on a single goal: building the world’s best clinical AI for physicians, by physicians.

[Pathway @PathwayMedical]

Today marks an exciting new chapter for Pathway: we’re joining @doximity!

Over the past 7 years, our physician-led team has built one of the largest structured datasets in medicine, purpose-built for AI. With it, we’ve delivered trusted, evidence-based clinical reference to hundreds of thousands of clinicians, including thousands of whom subscribe to our premium product.

Now, with Doximity, one of the most trusted platforms in healthcare, we’ll bring that same AI-powered clinical reference experience to millions of clinicians for free, built directly into the tools they already love and use at the point of care.

Learn more here: https://t.co/SstK6CxT2E

[Pathway @PathwayMedical]

#AskPathway — Can you optimize gout management for this patient?

https://t.co/pEVv6XmXlK

[Pathway @PathwayMedical]

#AskPathway — What are the established risk factors for developing acute diverticulitis in patients with known diverticulosis?

https://t.co/nSUsf1T3qP

[Pathway @PathwayMedical]

#AskPathway — When should prostate cancer screening begin, and how often should it be performed?

https://t.co/jDuoYBQsCp

[Pathway @PathwayMedical]

#AskPathway — What are the typical tremor frequency range, distribution, and other distinguishing characteristics in essential tremor?

https://t.co/GlbvP3HQ39

[Pathway @PathwayMedical]

#AskPathway — What is the optimal timing and duration of folate supplementation to achieve maximal protection against neural tube defects?

https://t.co/QfmKNE7Ugk

[Pathway @PathwayMedical]

#AskPathway — What is the most appropriate early targeted antimicrobial regimen for this patient?

A. Ceftriaxone 2 g IV q12hrs
B. Meropenem 2 g IV q8hrs, plus consideration of intraventricular amikacin
C. Vancomycin IV plus ampicillin/sulbactam IV
D. Levofloxacin IV monotherapy

https://t.co/vXqTveeN4b

[Pathway @PathwayMedical]

#AskPathway — Can you optimize the management of this patient with fulminant C. difficile infection?

https://t.co/62XKznhiCO

[Pathway @PathwayMedical]

#AskPathway — What does the presence of late-appearing T-wave notches in LQT3 suggest?

https://t.co/fKURwIs0rE

[Pathway @PathwayMedical]

#AskPathway — What are the preferred vasoconstrictor options for hepatorenal syndrome, and how is treatment response assessed?

https://t.co/Cg8GM60VOB

[Pathway @PathwayMedical]

#AskPathway — What are the safety considerations for using vaginal estrogen for genitourinary syndrome of menopause in women with a history of breast cancer?

https://t.co/cbdai7L9rn

[Pathway @PathwayMedical]

#AskPathway — Which strains of avian influenza have been most associated with severe human disease and mortality?

https://t.co/nc6JFN2BKk

[Pathway @PathwayMedical]

#AskPathway — Can you optimize the transfusion strategy for this ICU patient?

https://t.co/e0kydQhEHI

[Pathway @PathwayMedical]

How is pediatric critical asthma defined, and what is the recommended management? #DeepResearch
https://t.co/4zIoXXpcf9

[Pathway @PathwayMedical]

What is the recommended surveillance in patients with multifocal atrophic gastritis and a first-degree relative with gastric cancer? #DeepResearch
https://t.co/fQieglVFGH